SINGULAR HEALTH GROUP LTD — Director's Dealing 2022

Jan 3, 2022

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name	of	entitySingular Health Group Limited
ABN		58 639 242 765

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Thomas Hanly
Date of last notice	15 February 2021

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [408 x 280] intentionally omitted <==

----- Start of picture text ----- Direct or indirect interest Direct and IndirectNature of indirect interest Indirect(including registered holder) Securities held by Sylvan Capital Pte Ltd – anNote: Provide details of the circumstances giving rise to the relevant entity controlled by Mr Hanly, and of which he isinterest.a beneficiary.Date of change 30 December 2021No. of securities held prior to change Direct(i) 1 fully paid ordinary share – escrowed to12 February 2023(ii) 1,500,000 Class A Performance Rights –escrowed to 12 February 2023(iii) 1,500,000 Class B Performance Rights –escrowed to 12 February 2023(iv) 6,000,000 Unlisted Options ($0.30, 10February 2025), escrowed to 12 February2023Indirecti) 100,000 fully paid ordinary sharesii) 3,400,000 fully paid ordinary shares –escrowed to 12 February 2023Class Fully paid ordinary shares----- End of picture text -----

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

==> picture [409 x 364] intentionally omitted <==

----- Start of picture text ----- Number acquired Directi) 16,064Indirecti) NilNumber disposed NilValue/Consideration $4,738.88Note: If consideration is non-cash, provide details and estimatedvaluationNo. of securities held after change Direct(i) 1 fully paid ordinary share – escrowed to12 February 2023(ii) 1,500,000 Class A Performance Rights –escrowed to 12 February 2023(iii) 1,500,000 Class B Performance Rights –escrowed to 12 February 2023(iv) 6,000,000 Unlisted Options ($0.30, 10February 2025), escrowed to 12 February2023(v) 16,064 fully paid ordinary sharesIndirect(i) 100,000 fully paid ordinary shares(ii) 3,400,000 fully paid ordinary shares –escrowed to 12 February 2023Nature of change On-market purchaseExample: on-market trade, off-market trade, exercise of options, issueof securities under dividend reinvestment plan, participation in buy-back----- End of picture text -----

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [409 x 197] intentionally omitted <==

----- Start of picture text ----- Detail of contract n/aNature of interest n/aName of registered holder n/a(if issued securities)Date of change n/aNo. and class of securities to which n/ainterest related prior to changeNote: Details are only required for a contract inrelation to which the interest has changedInterest acquired n/a----- End of picture text -----

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Interest disposed	n/a
Value/ConsiderationNote: If consideration is non-cash, provide detailsand an estimated valuation	n/a
Interest after change	n/a

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed abovetraded during a+closed period where prior written clearance wasrequired?	No
If so, was prior written clearance provided to allow the trade toproceed during this period?	n/a
If prior written clearance was provided, on what date was thisprovided?	n/a

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3